Could a medication side effect score predict falls in older adults?

NCT ID NCT07813143

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

Falls are a leading cause of injury in older adults. This study examines whether taking many medications, the side effects those medications have on memory and balance, and age-related muscle loss are linked to fall risk. Researchers will enroll adults aged 65 and older who visit the emergency department. They will review medications, measure hand grip strength, and use ultrasound to check thigh muscle thickness. All measurements are non-invasive and done once during the visit. No experimental treatment is given.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers find clear links between medication burden, muscle loss, and falls, emergency departments could flag high-risk older adults earlier and connect them to fall prevention programs.
What could go wrong
This study only observes patients at one emergency visit, so it can show associations but not prove cause and effect. The findings may not apply to older adults outside the emergency department setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 333 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 65 years and older presenting to the Emergency Department of Gazi University Hospital, enrolled consecutively based on eligibility criteria.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 years or older * Presenting to the emergency department * Willing and able to provide written informed consent Exclusion Criteria: * Prior major upper or lower extremity surgery, prosthesis, or amputation preventing ultrasound or hand-grip strength measurement * Acute bilateral femur or hip fracture precluding measurement * Neuromuscular disease (e.g., ALS, myopathy) * Terminal or palliative status with limited ability to cooperate with measurements * Severe delirium or inability to cooperate with hand-grip testing * ECOG Performance Status of 3 or 4 * Bedbound status and/or stroke sequelae preventing assessment * Patients who decline to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anticholinergics are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gazi University

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.